Physician profile

Louis R Cappa

Foot & Ankle Surgery · New Windsor, NY

NPI 1689645905

$15,234.72

in general payments reported to CMS, 2019-2025

37 companies · $2,045 in 2025

The $2,045 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,429.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Organogenesis INC. $7,509.46 2019-2025 Puraply Wound Matrix, Affinity, Apligraf
Smith+Nephew, INC. $2,163.25 2019-2025 Renasys Touch, Pico, Collagenase Santyl
Stryker Corporation $978.50 2019-2025 Sonicanchor, Asnis, Dart-Fire
Paratek Pharmaceuticals, INC. $899.95 2020-2025 Nuzyra
Kci USA, INC. $633.25 2019-2023 V.A.C. Veraflo, V.A.C. Dermatac, Prevena
Tactile Systems Technology INC $389.13 2019-2025 Flexitouch Plus, Entre Plus, Nimbl
Integra Lifesciences Corporation $320.65 2019-2025 Integra, Primatrix, Integra Dermal Regeneration Template
Bioventus LLC $271.80 2019-2023 Theragenesis Bilayer Wound Matrix, Sonicone Clinic
Seapearl East, INC $186.39 2020-2023
Misonix INC $172.91 2019-2021
Next Science LLC $161.07 2023 Xperience, Blastx, Surgx
Kerecis Limited $148.86 2023-2025 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Averitas Pharma INC. $120.93 2023-2025 Qutenza
Abbott Laboratories $118.33 2023 Freestyle Libre
Treace Medical Concepts, INC. $106.97 2024-2025
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Advanced Oxygen Therapy INC. $104.59 2022-2025 Topical Oxygen Chamber For Extremities
Grt US Holding, INC. $101.87 2022
Merck Sharp & Dohme LLC $94.57 2019
Mimedx Group, INC. $81.16 2024-2025
Zimmer Biomet Holdings, INC. $73.90 2019-2022
Medtronic, INC. $64.44 2022-2025 Intellis Adaptivestim
Solventum Corporation $59.29 2024-2025 Activ.A.C., Promogran Prisma, V.A.C.Ulta
Reprise Biomedical, INC. $50.35 2024-2025 Miro3d
Reddress USA, INC. $47.46 2024
Abbvie INC. $44.42 2024-2025
Ets Wound Care LLC $42.83 2024 Mirragen Advanced Wound Matrix
Urgo Medical North America, LLC $42.81 2025 Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap
Hydrofera LLC $39.36 2023 Hydrofera Blue
Melinta Therapeutics, LLC $37.41 2019
Polynovo North America LLC $32.53 2024 Novosorb Btm
Nalu Medical, INC. $26.48 2022
Horizon Therapeutics Plc $26.28 2021
Heron Therapeutics, INC. $21.58 2021
Kowa Pharmaceuticals America, INC. $20.15 2022
Axogen $16.28 2019
Paragon 28, INC. $15.22 2021
Lifenet Health $10.29 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Louis R Cappa

$15,234.72

in general payments reported 2019-2025

Years
2019-2025
Top company
Organogenesis INC.
Context
The $2,045 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/348392/louis-r-cappa

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.